Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KERENDIA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/KERENDIA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

KERENDIA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Bayer Ag🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 18, 2022
Approval ID: 10bb1b1e583cd295
Company: Bayer Ag
Type: Standard

Approval Details

Approval Id: 10bb1b1e583cd295
Drug Cima Aemps Name: KERENDIA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1211616007
Holder Company Name: Bayer Ag
Marketing Company Name: Bayer Hispania S.L.
Holder Company Detail Path: /organization/bayer-ag
Authorization Date: 2022-03-18
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Bayer Ag
Company Detail Path: /organization/bayer-ag

Company Information

Pharmaceutical Company Name: BAYER AG
Name En: Bayer AG
Country Name: Germany
City Name: Leverkusen
Address: Leverkusen, North Rhine-Westphalia, Germany
Website: https://www.bayer.com

Active Ingredients

FINERENONA

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 18, 2022

Approval ID

10bb1b1e583cd295

Type

Standard

Back to CIMA-AEMPS Approvals